(296 days)
Not Found
No
The description details a system that calculates FEV1 and Peak Flow based on the frequency of an acoustic tone, which is proportional to airflow. This is a direct measurement and calculation based on physical principles, not AI/ML. The document explicitly states "Mentions AI, DNN, or ML: Not Found".
No
The device is intended for monitoring FEV1 and PEF, which are diagnostic measurements, not therapeutic interventions. While these measurements may inform treatment, the device itself does not provide therapy.
Yes
This device monitors FEV1 and PEF, which are physiological measurements used in the diagnosis and management of respiratory conditions.
No
The device description explicitly states that the Wing system includes a "Wing Sensor" which is a physical component consisting of a plastic shell, electronics module, microphone, and audio cable. This sensor is essential for data acquisition and is not solely software.
Based on the provided text, the Wing device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the human body. The Wing device measures airflow as it is expelled from the body. It doesn't analyze blood, urine, tissue, or any other sample taken from the user.
- The intended use is monitoring lung function. The device measures FEV1 and PEF, which are physiological parameters related to breathing, not diagnostic markers found in a sample.
- The mechanism of action is based on airflow measurement. The device uses an acoustic transducer and microphone to measure the frequency of oscillations in the airstream, which is proportional to flow rate. This is a physical measurement of a bodily function, not a chemical or biological analysis of a sample.
Therefore, the Wing device falls under the category of a medical device that measures physiological parameters, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
Wing is intended for monitoring FEV1 (Forced exhalation in the first second) and PEF (Peak Expired Flow Rate) for home use. The device is designed for pediatric to adult users. Wing is not recommended for children under 5 years of age.
Product codes
BZH
Device Description
The Wing® Smart FEV1 and Peak Flow Meter (Wing) is an electronic peak flow monitor, that measures Peak Flow and FEV1. Wing is not recommended for children under 5 years of age.
The Wing Sensor consists of a plastic shell and a detachable electronics module. The plastic shell includes a built-in mouthpiece and an acoustic transducer. The electronics module houses a PCBA with a microphone and a 3.5mm audio cable. The audio cable is plugged into the 3.5mm audio jack (headphone jack) of a smartphone to transmit audio data to the Wing Software. The Wing Software, which includes the Wing Mobile Application (Wing App), the Wing Signal Processing Engine, and the Sparo Labs Data Management System, is used to collect, transmit, manage, store, and calculate FEV1 and Peak Flow measurements.
When taking a lung function measurement, the user launches the Wing App, which serves as Wing's user interface, on his or her smartphone and connects the Wing Sensor by plugging it into the smartphone's headphone jack. The Wing App prompts the user to perform the lung function test after the user has indicated that they would like to take a lung function measurement. As the user blows through Wing Sensor, the acoustic transducer induces oscillations in the airstream and an acoustic tone is created by the airstream. The microphone, located in the electronics module, detects this acoustic tone. The frequency of the acoustic tone (i.e. the number of oscillations) is proportional to flow rate of the air as it passes through the acoustic transducer. With flow rate and correspondent time, the FEV1 can be calculated. Wing is provided non-sterile.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
pediatric to adult users. Wing is not recommended for children under 5 years of age.
Intended User / Care Setting
home use.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance Testing:
The following performance data were provided in support of the substantial equivalence determination: Bench testing, biocompatibility testing, applicable electrical safety testing, and software validation & verification testing.
Bench Testing:
Wing was tested to and passed the American Thoracic Society (ATS) 24 and 26 Standard Waveforms using a pulmonary waveform generator, meeting ATS accuracy and precision recommendations for measuring FEV1 and Peak Flow.
Biocompatibility Testing:
The biocompatibility evaluation for the Wing device was conducted in accordance with the FDA Blue Book Memorandum #G95-1 "Use of International Standard ISO-10993, 'Biological Evaluation of Medical Devices Part 1: Evaluation and Testing,"" May 1, 1995, and International Standard ISO 10993-1 "Biological Evaluation of Medical Devices – Part 1: Evaluation and Testing Within a Risk Management Process," as recognized by FDA. The test articles were prepared in accordance with ISO 10993-12, Cytotoxicity testing was completed in accordance with ISO 10993-5, and Sensitization and Irritation testing were completed in accordance with ISO 10993-10.
Electrical Safety Testing:
Electrical safety testing was conducted on the Wing Sensor, showing the system complies with the IEC 60601-1 standard.
Electromagnetic Compatibility (EMC) Testing:
Electromagnetic compatibility (EMC) testing was conducted on the Wing Smart FEV1 and Peak Flow Meter, showing the system complies with the IEC 60601-1-2 standard.
Software Validation & Verification Testing:
Software verification and validation testing were conducted and documentation was provided as recommended by FDA's Guidance , "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices", and the software for this device was considered as a "moderate" level of concern.
Animal & Clinical Testing:
The subject of this premarket submission, Wing, did not require animal or clinical studies to support substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
ATS accuracy & precision recommendations for measuring FEV1 and Peak Flow.
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.1860 Peak-flow meter for spirometry.
(a)
Identification. A peak-flow meter for spirometry is a device used to measure a patient's maximum ventilatory flow rate.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular emblem with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is a stylized image of an eagle with its wings spread, symbolizing the department's mission to protect the health of all Americans.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
June 3, 2016
Sparo Inc. Ms. Mona Dean Consultant, Regulatory Affairs 911 Washington Ave, #809 Saint Louis. Missouri 63101
Re: K152276
Trade/Device Name: Wing Smart FEV1 and Peak Flow Meter Regulation Number: 21 CFR 868.1860 Regulation Name: Peak-Flow Meter for Spirometry Regulatory Class: II Product Code: BZH Dated: August 8. 2015 Received: May 5, 2016
Dear Mona Dean:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Tina Kiang
-s
for Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital. Respiratory. Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Image /page/2/Picture/0 description: The image shows the logo for Sparo Labs. The logo consists of a geometric shape resembling a bird above the words "SPARO LABS". The bird is made up of several triangles and lines, giving it a modern and minimalist look.
4. INDICATIONS FOR USE STATEMENT
| DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration | Form Approved: OMB No. 0910-0120
Expiration Date: January 31, 2017
See PRA Statement below. |
| ------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------- |
|---|
Indications for Use
| 510(k) Number (if known) | K152276 |
|---|---|
| Device Name | Wing Smart FEV1 and Peak Flow Meter |
| Indications for Use (Describe) | Wing is intended for monitoring FEV1 (Forced exhalation in the first second) and PEF (Peak Expired Flow Rate) for home use. The device is designed for pediatric to adult users. Wing is not recommended for children under 5 years of age. |
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
|---|---|
| -------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------ |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete
time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number,"
FORM FDA 3881 (8/14)
Page 1 of 1
PSC Publishing Services (301) 443-6740 EF
3
Image /page/3/Picture/0 description: The image shows the logo for Sparo Labs. The logo consists of a geometric bird figure above the words "SPARO LABS". The bird is made up of several triangles and quadrilaterals, giving it a modern, minimalist look.
510(K) SUMMARY
| Manufacturer: | Sparo Inc. (d.b.a Sparo Labs) |
|---|---|
| Contact: | Mona Dean |
| Consultant, Regulatory Affairs | |
| 913-638-1954 (phone) | |
| monadeans@gmail.com | |
| Date Prepared: | June 2, 2016 |
| Product Code: | |
| Device Trade Name: | |
| Regulation Description: | |
| Classification: | BZH |
| Wing Smart FEV1 and Peak Flow Meter | |
| Peak-flow meter for spirometry | |
| 21 CFR 868.1860 |
ll
Indications for Use:
Class:
Wing is intended for monitoring FEV1 (Forced exhalation in the first second) and PEF (Peak Expired Flow Rate) for home use. The device is designed for pediatric to adult users. Wing is not recommended for children under 5 years of age.
Device Description:
The Wing® Smart FEV1 and Peak Flow Meter (Wing) is an electronic peak flow monitor, that measures Peak Flow and FEV1. Wing is not recommended for children under 5 years of age.
The Wing Sensor consists of a plastic shell and a detachable electronics module. The plastic shell includes a built-in mouthpiece and an acoustic transducer. The electronics module houses a PCBA with a microphone and a 3.5mm audio cable. The audio cable is plugged into the 3.5mm audio jack (headphone jack) of a smartphone to transmit audio data to the Wing Software. The Wing Software, which includes the Wing Mobile Application (Wing App), the Wing Signal Processing Engine, and the Sparo Labs Data Management System, is used to collect, transmit, manage, store, and calculate FEV1 and Peak Flow measurements.
When taking a lung function measurement, the user launches the Wing App, which serves as Wing's user interface, on his or her smartphone and connects the Wing Sensor by plugging it into the smartphone's headphone jack. The Wing App prompts the user to perform the lung function test after the user has indicated that they would like to take a lung function measurement. As the user blows through Wing Sensor, the acoustic transducer induces oscillations in the airstream and an acoustic tone is created by the airstream. The microphone, located in the electronics module, detects this acoustic
4
Image /page/4/Picture/0 description: The image shows the logo for Sparo Labs. The logo consists of a geometric bird design above the words "SPARO LABS". The bird is made up of several triangles and lines, giving it a modern and minimalist look.
tone. The frequency of the acoustic tone (i.e. the number of oscillations) is proportional to flow rate of the air as it passes through the acoustic transducer. With flow rate and correspondent time, the FEV1 can be calculated. Wing is provided non-sterile.
Predicate Device:
Wing was shown substantially equivalent to the previously cleared device: Microlife Electronic Peak Flow Monitor, with PEF and FEV1, Models PF-100 and PF-100-1 (with software) – K040723.
Substantial Equivalence
Technological Characteristics:
The Wing Sensor measuring principle is determination of respiratory flow using acoustic sensor (meeting ATS accuracy & precision testing) whereas the predicate device uses a infrared rotary flow sensor. Both technologies measure frequency of oscillation (or rotation) caused by the airstream to calculate FEV1 and PEF. Both devices meet ATS accuracy & precision recommendations. The Wing Sensor also uses a 3.5mm audio jack (headphone jack) to transmit data to the Patient Mobile Device (e.g. an iPhone), whereas the predicate device uses a mini-USB port to transmit data to a computer and associated tracking software. The Wing Sensor contains no battery and draws power directly from the Patient Mobile Device via the 3.5mm audio jack, whereas the predicate device is powered by 2 AAA batteries.
Performance Testing:
The following performance data were provided in support of the substantial equivalence determination: Bench testing, biocompatibility testing, applicable electrical safety testing, and software validation & verification testing.
Bench Testing:
Wing was tested to and passed the American Thoracic Society (ATS) 24 and 26 Standard Waveforms using a pulmonary waveform generator, meeting ATS accuracy and precision recommendations for measuring FEV1 and Peak Flow.
Biocompatibility Testing:
The biocompatibility evaluation for the Wing device was conducted in accordance with the FDA Blue Book Memorandum #G95-1 "Use of International Standard ISO-10993, 'Biological Evaluation of Medical Devices Part 1: Evaluation and Testing,"" May 1, 1995, and International Standard ISO 10993-1 "Biological Evaluation of Medical Devices – Part 1: Evaluation and Testing Within a Risk Management Process," as recognized by FDA. The test articles were prepared in accordance with ISO 10993-12, Cytotoxicity testing was completed in accordance with ISO 10993-5, and Sensitization and Irritation testing were completed in accordance with ISO 10993-10.
5
Image /page/5/Picture/0 description: The image shows the logo for Sparo Labs. The logo consists of a geometric bird figure above the words "SPARO LABS". The bird is made up of several triangles and quadrilaterals, giving it an origami-like appearance.
Electrical Safety Testing:
Electrical safety testing was conducted on the Wing Sensor, showing the system complies with the IEC 60601-1 standard.
Electromagnetic Compatibility (EMC) Testing:
Electromagnetic compatibility (EMC) testing was conducted on the Wing Smart FEV1 and Peak Flow Meter, showing the system complies with the IEC 60601-1-2 standard.
Software Validation & Verification Testing:
Software verification and validation testing were conducted and documentation was provided as recommended by FDA's Guidance , "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices", and the software for this device was considered as a "moderate" level of concern.
Animal & Clinical Testing:
The subject of this premarket submission, Wing, did not require animal or clinical studies to support substantial equivalence.
Conclusion:
Wing was shown to be substantially equivalent to the Microlife Electronic Peak Flow Monitor, with PEF and FEV1, Models PF-100-1 (with software) with respect to intended use, indications for use, technological characteristics, performance characteristics, and biocompatibility.